Polymorphism for Interleukin-4 (-590 C/T) Promoter: Non-Association with Endometriosis

Authors

  • Rika Hairunisyah Ministry of Health, Poltekkes Kemenkes Palembang, Indonesia
  • Siti Fatimah Ministry of Health, Poltekkes Kemenkes Palembang, Indonesia

DOI:

https://doi.org/10.56988/chiprof.v1i1.2

Keywords:

Polymorphism, Interleukin-4 gene (-590T/C), endometriosis

Abstract

Endometriosis is a benign gynecological disorder that often occurs in women of reproductive age, usually characterized by endometrial epithelium and stroma outside their usual location. It is estimated that this disease affects 56% of women worldwide. Various types of cytokines are associated with endometriosis, including interleukin IL-4, which inhibits the production of proinflammatory cytokines that stimulate active B cells and T cell proliferation, the differentiation of B cells into plasma cells. Il-4 promoter region polymorphism (-590C/T) is involved in genetic susceptibility to endometriosis. This study aims to determine whether Gen IL-4
(-590C/T) polymorphism indicates endometriosis. This study is an analytical observational study conducted at the Laboratory of Molecular Biology in Palembang City in August 2021, with the approach of Case-Control study. There were 70 samples divided into two groups, namely 35 cases and 35 controls. Determination of genotypes and alleles using PCR-RFLP and chi-square analyzed data to determine the relationship. The results showed no significant difference. The genomorphism of the Interleukin-4(-590C/T) gene cannot be used to indicate endometriosis susceptibility.

References

J. Kitawaki et al., “Interferon-γ gene dinucleotide (CA) repeat and interleukin-4 promoter region (-590C/T) polymorphisms in Japanese patients with endometriosis,” Hum. Reprod., vol. 19, no. 8, pp. 1765–1769, 2004, doi: 10.1093/humrep/deh337.

Y. Y. Hsieh, C. C. Chang, F. J. Tsai, Y. Hsu, H. Der Tsai, and C. H. Tsai, “Polymorphisms for interleukin-4 (IL-4) -590 promoter, IL-4 intron3, and tumor necrosis factor alpha -308 promoter: Non-association with endometriosis,” J. Clin. Lab. Anal., vol. 16, no. 3, pp. 121–126, 2002, doi: 10.1002/jcla.10021.

X. Lin et al., “Excessive oxidative stress in cumulus granulosa cells induced cell senescence contributes to endometriosis-associated infertility,” Redox Biol., vol. 30, no. December 2019, p. 101431, 2020, doi: 10.1016/j.redox.2020.101431.

Sarwono Prawirohardjo, “Ilmu Kebidanan.” 2016.

E. García-Gómez, E. R. Vázquez-Martínez, C. Reyes-Mayoral, O. P. Cruz-Orozco, I. Camacho-Arroyo, and M. Cerbón, “Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis,” Front. Endocrinol. (Lausanne)., vol. 10, no. January, 2020, doi: 10.3389/fendo.2019.00935.

C. Hernandes et al., “Microbiome profile of deep endometriosis patients: Comparison of vaginal fluid, endometrium and lesion,” Diagnostics, vol. 10, no. 3, 2020, doi: 10.3390/diagnostics10030163.

O. B. Christiansen, H. S. Nielsen, and A. M. Kolte, “Future directions of failed implantation and recurrent miscarriage research,” Reprod. Biomed. Online, vol. 13, no. 1, pp. 71–83, 2006, doi: 10.1016/S1472-6483(10)62018-4.

F. M. Reis, L. M. Coutinho, S. Vannuccini, F. Batteux, C. Chapron, and F. Petraglia, “Progesterone receptor ligands for the treatment of endometriosis: The mechanisms behind therapeutic success and failure,” Hum. Reprod. Update, vol. 26, no. 4, pp. 565–585, 2020, doi: 10.1093/humupd/dmaa009.

M. Králíčková, “Endometriosis: Are Stem Cells Involved?,” Int. J. Clin. Exp. Med. Sci., vol. 1, no. 3, p. 65, 2015, doi: 10.11648/j.ijcems.20150103.16.

S. W. Guo, “The pathogenesis of adenomyosis vis-à-vis endometriosis,” J. Clin. Med., vol. 9, no. 2, 2020, doi: 10.3390/jcm9020485.

C. Calhaz-Jorge, A. P. Costa, M. Barata, M. C. Santos, A. Melo, and M. L. Palma-Carlos, “Tumour necrosis factor α concentrations in the peritoneal fluid of infertile women with minimal or mild endometriosis are lower in patients with red lesions only than in patients without red lesions,” Hum. Reprod., vol. 15, no. 6, pp. 1256–1260, 2000, doi: 10.1093/humrep/15.6.1256.

J. Halme, “Release of tumor necrosis factor-α by human peritoneal macrophages in vivo and in vitro,” Am. J. Obstet. Gynecol., vol. 161, no. 6 PART 1, pp. 1718–1725, 1989, doi: 10.1016/0002-9378(89)90957-5.

C. C. Hsu, B. C. Yang, M. H. Wu, and K. E. Huang, “Enhanced interleukin-4 expression in patients with endometriosis,” Fertil. Steril., vol. 67, no. 6, pp. 1059–1064, 1997, doi: 10.1016/S0015-0282(97)81439-2.

X. Li et al., “The effects of gene polymorphisms in interleukin-4 and interleukin-6 on the susceptibility of rheumatoid arthritis in a Chinese population,” Biomed Res. Int., vol. 2014, 2014, doi: 10.1155/2014/265435.

Y. M. Hussein, A. S. El-Shal, N. A. Rezk, S. M. Abdel Galil, and S. S. Alzahrani, “Influence of interleukin-4 gene polymorphisms and interleukin-4 serum level on susceptibility and severity of rheumatoid arthritis in Egyptian population,” Cytokine, vol. 61, no. 3, pp. 849–855, 2013, doi: 10.1016/j.cyto.2013.01.001.

N. Buchs et al., “IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction,” Rheumatology, vol. 39, no. 10, pp. 1126–1131, 2000, doi: 10.1093/rheumatology/39.10.1126.

F. Castro, E. Acevedo, E. Ciusani, J. A. Angulo, F. A. Wollheim, and M. Sandberg-Wollheim, “Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis,” Ann. Rheum. Dis., vol. 60, no. 8, pp. 791–795, 2001, doi: 10.1136/ard.60.8.791.

P. W. Mathieson, “Immune dysregulation in minimal change nephropathy,” Nephrol. Dial. Transplant., vol. 18, no. SUPPL. 6, pp. 26–29, 2003, doi: 10.1093/ndt/gfg1066.

P. Jiang et al., “IL-4Rα polymorphism is associated with myasthenia gravis in Chinese Han population,” Front. Neurol., vol. 9, no. JUL, pp. 1–8, 2018, doi: 10.3389/fneur.2018.00529.

I. B. Wu, H. M. M. Tendean, and M. E. Mewengkang, “Gambaran Karakteristik Penderita Endometriosis di RSUP Prof. Dr. R. D. Kandou Manado,” e-CliniC, vol. 5, no. 2, 2017, doi: 10.35790/ecl.5.2.2017.18568.

Y. Yeni Elviani, Ira Kusumawaty, “Menurunkan Kecanduan Game Dengan Penerapan Peraturan Penggunaan Ponsel Selama Pembelajaran Online Pendidikan dan Kebudayaan Republik dilaksanakan Covid-19 melalui observasi lingkungan sekitar yang Metode Penelitian potong lintang menilai siswa sekolah 589,” vol. 4, no. 2, 2021, doi: 10.32524/jksp.v4i2.268.

I. Kusumawaty, Yunike, Jawiah, and Rehana, “Family resilience in caring for drug addiction,” Gac. Sanit., vol. 35, pp. S491–S494, 2021, doi: 10.1016/j.gaceta.2021.10.079.

S. N. K. Ira Kusumawaty , Yunike Yunike, “Hubungan Komunikasi Asertif dengan Cyber-bullying pada Remaja,” J. Kedokt. Brawijaya, vol. 31, no. 4, pp. 2–6, 2021.

I. Kusumawaty, R. Surahmat, S. Martini, and Muliyadi, “Family Support For Members in Taking Care of Mental Disordered Patients,” Proc. First Int. Conf. Heal. Soc. Sci. Technol. (ICoHSST 2020), vol. 521, no. ICoHSST 2020, pp. 115–120, 2021, doi: 10.2991/assehr.k.210415.026.

Downloads

Published

2022-02-28

How to Cite

Hairunisyah, R. ., & Fatimah, S. . (2022). Polymorphism for Interleukin-4 (-590 C/T) Promoter: Non-Association with Endometriosis. International Journal Scientific and Professional, 1(1), 10–16. https://doi.org/10.56988/chiprof.v1i1.2

Issue

Section

Articles